What kind of investment did Aligned Modern Health receive?

Arcventis Health Partners made a majority growth investment in Aligned Modern Health. Harbour Point Capital remains a meaningful investor, while the amount, valuation, and detailed ownership terms were not disclosed.

What does Aligned Modern Health do?

Aligned Modern Health provides functional medicine, hormone health, peptide therapy, chiropractic care, and acupuncture through Chicago-area clinics and a multi-state telehealth practice. The company says its model combines clinical oversight, diagnostics, and personalized treatment plans.

How will Aligned Modern Health use the investment?

The company says the partnership will support national expansion, broader clinical offerings, investment in its digital patient experience, and growth of provider and clinical teams.

Why is multi-state telehealth expansion operationally difficult?

A telehealth visit is generally regulated where the patient is located, so expansion requires licensed clinicians, state-aware protocols, and consistent clinical oversight. Interstate compacts can reduce licensing friction, but they do not remove the need to manage provider capacity and state requirements.

Why does Aligned Modern Health's insurance model matter?

Aligned Modern Health says it accepts most major insurance plans for visits and bloodwork. That can make its services accessible beyond a purely self-pay or concierge customer base, while adding reimbursement and network-management work as the company scales.

Aligned Modern Health Gets Arcventis Majority Investment

Aligned Modern Health has received a majority growth investment from Arcventis Health Partners, with existing backer Harbour Point Capital remaining a meaningful investor. The parties announced the transaction on September 24, 2026, but did not disclose the amount, valuation, or detailed ownership terms.

The Chicago-founded healthcare provider says the partnership will support national expansion, broader clinical services, investment in its digital patient experience, and growth of its provider and clinical teams. Those plans push Aligned Modern Health further from a regional clinic network toward a multi-state care platform, where personalized medicine has to survive the operational realities of licensing, staffing, insurance, and digital continuity.

The transaction also arrives as Aligned Modern Health broadens its clinical menu. The company launched peptide therapy in 2026 after introducing hormone replacement therapy for men and women in 2025, adding those services to functional medicine, chiropractic care, and acupuncture.

What Aligned Modern Health announced

Arcventis described the deal as a majority growth investment in Aligned Modern Health. Harbour Point, which previously backed the company, will remain invested. The official announcement does not state the transaction size or specify how much of the investment is primary capital for the company versus secondary liquidity for existing holders.

That distinction matters because this is not a conventional venture round with a disclosed amount and valuation. It is a control-oriented growth transaction built around an operating expansion. Arcventis invests in healthcare growth equity and growth buyouts, including significant minority and majority positions, while Harbour Point focuses on high-growth healthcare services businesses.

Virginia Materese, CEO of Aligned Modern Health, said the partnership will help the company expand nationally, broaden its services, improve its digital patient experience, and add providers and clinical staff. Fazeela Abdul Rashid, co-founder and managing partner of Arcventis, framed the company as a patient-centered platform spanning preventive care, longevity medicine, women's health, and chronic disease management.

A Chicago clinic model moving across state lines

Aligned Modern Health was founded in Chicago in 2010. Public company records identify Brian Carey, Andrew Ingley, William Fiely, and Ryan O'Toole as co-founders, while Materese has led the company as CEO since 2023. The company says its current clinical team includes more than 100 doctors, nurse practitioners, and clinicians.

The announcement reports 15 clinics across Chicago and a telehealth practice serving patients in more than 20 states. Aligned Modern Health's current locations page shows the breadth of that footprint, with clinics in Chicago and surrounding suburbs alongside state-specific virtual-care offerings.

The physical and virtual channels do different jobs. Clinics provide in-person access to functional medicine, hormone health, chiropractic care, and acupuncture, while telehealth extends parts of the medical model beyond Illinois. The investment is therefore funding more than geographic marketing. It is funding the systems needed to make a care relationship work across distance.

Why the insurance model matters

Aligned Modern Health says it accepts most major insurance plans for visits and bloodwork. That feature matters in a market where many longevity, functional medicine, and concierge offerings depend heavily on self-pay customers. Insurance participation can widen access, but it also introduces reimbursement, eligibility, documentation, and network-management work that has to scale with patient demand.

The company's stated model combines physician-led oversight, diagnostic testing, and individualized treatment plans. Its commercial opportunity sits between patients looking for more coordinated help with chronic or unresolved symptoms and a healthcare system that often distributes those needs across separate visits, specialists, labs, and payment rules.

Arcventis is underwriting the possibility that Aligned Modern Health can make that coordination repeatable. The growth plan will have to add clinical capacity and digital convenience without reducing the model to a collection of loosely connected services.

Telehealth expansion is an operating challenge

National telehealth growth depends on more than video appointments. U.S. Department of Health and Human Services guidance states that a telehealth visit occurs in the state where the patient is located. Interstate compacts can make multi-state practice easier, but provider licensing, scope-of-practice rules, clinical protocols, and oversight still shape how quickly a healthcare organization can expand.

For Aligned Modern Health, adding states means matching demand with appropriately licensed clinicians and maintaining consistent care across a larger network. The company's plan to grow provider and clinical teams is therefore central to the transaction, not a routine hiring footnote. Digital investment can improve access and coordination, but the patient experience still depends on who is available, what they can legally provide, and how well the clinical record follows the patient.

The clinical offering is getting broader

The company launched hormone replacement therapy for men and women in 2025 and added peptide therapy in 2026. Aligned Modern Health presents those services within a broader care model that also includes functional medicine, chiropractic care, and acupuncture. The company says peptide protocols may support needs such as weight management, age-related hormone changes, performance, and recovery under clinical supervision.

Those offerings place the company in a fast-growing but demanding part of healthcare. Consumer interest can create the appointment, but clinical oversight, evidence boundaries, patient selection, and follow-through determine whether a broader menu becomes a durable care platform. The announcement does not provide audited patient outcomes or financial performance, so those remain open questions rather than proof points.

What Arcventis and Harbour Point are backing

Arcventis is a U.S.-focused healthcare investor launched in 2025 by Abdul Rashid and Richard Pines. The firm targets growth-stage healthcare companies and says it can invest in primary and secondary transactions, organic expansion, and acquisitions. Aligned Modern Health fits that mandate as an established services business seeking to move beyond a regional footprint.

Harbour Point's decision to remain a meaningful investor adds continuity. The firm has supported Aligned Modern Health through an earlier growth phase and is staying involved as Arcventis takes the majority position. That structure suggests the next chapter is meant to build on the existing platform rather than replace its operating thesis.

What this transaction puts in motion

The majority investment gives Aligned Modern Health a new ownership partner for a national expansion built around clinics, telehealth, insurance participation, and an expanding service line. The money matters, even though the amount is private. The larger commitment is operational: turning a personalized care model into a consistent experience across more clinicians, more states, and more patient needs.

Materese and the Aligned Modern Health team now have to make scale feel less fragmented to the patient than the system they are asking that patient to leave behind. Arcventis and Harbour Point are carrying that obligation with them as the company moves beyond its Chicago base.